Screening embryos for polygenic disease risk: epidemiological, clinical, and ethical considerations
registration open until 10 April 2025 | eCampus
ESHRE Webinar
organised by the ESHRE Special Interest Group Reproductive Genetics
Type
Advanced
Learning objectives
We review the implementation, estimated benefits, personal and societal harms, and clinical considerations of prioritising IVF embryos based on their risk for polygenic conditions, such as breast cancer, hypertension, diabetes, or schizophrenia.
Course description
In this webinar, we will present the recently developed review paper on polygenic embryo screening, prepared by ESHRE delegates and experts in the field. Given the interdisciplinary nature of the outcomes and implications of PES, ranging from embryology, statistical genetics, epidemiology, reproductive medicine, and ethics, we will provide self-contained presentations to reproductive specialists interested in PES followed by a review of key arguments for and against the introduction of PES.
Target audience
Reproductive geneticists, genetic counselors, gynecologists, embryologists
Needs assessment
The development of new polygenic risk score tools for reproductive genetics is fast and their potential is revolutionary but still debatable. Despite a heated debate around this new technology and concerned statements of scientific society on its clinical utility, it is already available to IVF patients in some countries.
Expected educational outcomes
To provide a self-contained educational background to reproductive specialists interested in the subject and a comprehensive and critical review of arguments for and against the potential application of PES.
Programme
17:00 - 17:05
|
Introduction by Antonio Capalbo and Todd Lencz
|
17:05 - 17:25
|
Overview of the epidemiological and clinical considerations of PES by Shai Carmi
|
17:25 - 17:45
|
Overview of the ethical considerations of PES by Heidi Mertes
|
17:45 - 18:00 |
Q&A moderated by Antonio Capalbo and Todd Lencz
|